English 
CN
BIOCHINA 2026 (11th Edition) ECHEMI Biotech Industry Exhibition was held at Suzhou International Expo Center from March 12 to 14. Centered on the four core systems of Exhibition –Conference–Business Matching–Events, the conference built a high-end communication and cooperation platform covering the entire industrial chain.
At this exhibition, Hanbon Technology made an appearance at Booth 52–57 in Hall D3 (Pharmaceutical Equipment), setting up a professional exhibition area to present a panoramic view of the company’s one-stop solutions in chromatography technology.
Through systematic displays of chromatography resins, separation and purification equipment, process development services, and intelligent control systems, Hanbon Technology fully demonstrated its entire industrial chain layout of chromatography technology from laboratory R&D to industrial production, highlighting its sustained innovative technological strength and platform-based service capabilities in the biopharmaceutical field.
Featured Products
At the exhibition site, Hanbon Technology focused on showcasing core equipment including the overall solution for GLP-1 drug production, production-grade low-pressure chromatography systems, laboratory chromatography systems, and nucleic acid synthesizers, alongside a full range of chromatography resin products, comprehensively presenting the company’s technological layout in the downstream biopharmaceutical industry chain.
The booth attracted numerous industry experts and professional visitors for in-depth exchanges. The company’s technical team provided detailed on-site explanations and Q&A sessions focusing on equipment performance and technical advantages.
GLP-1 Production Solution
Hanbon Technology has built a dual-track chromatography technology matrix of low-pressure and medium-high pressure, establishing a unique technological barrier in the purification of insulin and peptides. Relying on a full-process solution covering online dilution/dosing systems, automatic ultrafiltration modules, solvent recovery systems, and supporting piping and tank engineering, it provides end-to-end turnkey projects from crude purification to fine purification, with continuously rising market recognition.
Its purification production line builds a data hub system based on the DCS + Batch dual-platform architecture, realizing full-link traceability of production parameters. It also integrates an automatic control management system for centralized data collection, unified management, and centralized control, as well as a batch processing and batch control management system, making data transmission and management more efficient and transparent, and greatly reducing human intervention.
With dual compliance guarantees of FDA 21 CFR Part 11 / EU GMP Annex 11, it builds a solid line of defense for data integrity.
MCC Manual Chromatography Column
The MCC series manual chromatography columns adopt a manual screw compression method for resin packing, featuring a simple configuration, easy cleaning and disinfection, and convenient manual operation, suitable for switching between diversified products.
With a compact structural design, user-friendly operation, and stable performance, the columns meet the application requirements of most chromatography resins. They deliver excellent packing performance and high column efficiency, satisfying customers’ needs from pilot scale to large-scale production.
ACC Automatic Axial Compression Chromatography Column
The ACC series automatic axial compression chromatography columns ensure high consistency in every packing run through intelligent column-packing technology, thereby guaranteeing the reproducibility of chromatography results, effectively reducing risks caused by batch-to-batch variations in production, and improving the stability of product quality.
The ACC series is widely applicable (covering monoclonal antibodies, vaccines, blood products, etc.), compatible with most chromatography resin types and diverse column-packing processes in the biopharmaceutical field, making it an ideal solution for diversified production needs.
Bio-Oligo Laboratory Nucleic Acid Synthesizer
The Bio-Oligo oligonucleotide synthesizer is a highly efficient, fast, and reliable device designed specifically for research and process development laboratories. The series currently offers three scale options for customers:
Bio-Oligo 10: for 10 μmol to 50 μmol synthesis scale
Bio-Oligo 100: for 50 μmol to 9 mmol synthesis scale
Bio-Oligo 150: for 100 μmol to 12 mmol synthesis scale
Featuring an innovative modular design combined with intelligent software and multiple specifications of synthesis columns, it supports robust and easily scalable DNA/RNA synthesis processes from basic research to process development. Processes can be seamlessly transferred to higher-capacity synthesis equipment, ensuring high-yield and high-quality scaled-up production.
Bio-Lab Laboratory Chromatography System
The Bio-Lab laboratory chromatography system is a highly efficient, fast, and reliable fully automatic chromatography device developed by the company, used for the rapid purification of biological molecules such as proteins, peptides, and nucleic acids at microgram to gram scale.
Adopting a modular design and intelligent software, combined with chromatography columns of different specifications, it meets the purification needs of various biological macromolecules in the laboratory.
Bio-Lab TFF Laboratory Ultrafiltration System
The Bio-TFF series automatic tangential flow filtration system is an easy-to-use automatic ultrafiltration (UF)/diafiltration (DF) system, suitable for harvesting, clarification, concentration, and buffer exchange in R&D and pilot-scale production of antibodies, vaccines, nucleic acid drugs, and other biopharmaceuticals.
The equipment features fully automatic intelligent design with automatic TMP control, enabling automatic concentration, constant-volume diafiltration, automatic collection, and automatic data recording. Multiple models are available (Bio-TFF 30/180/850, etc.) to meet the requirements of different membrane materials.
Engaging Interactions
During the exhibition, the Hanbang Technology team conducted in-depth exchanges with new and existing customers in the biopharmaceutical field. Through systematic product explanations and scenario-based technical demonstrations, the team conveyed the professionalism, depth, and thoughtfulness of its services.
In in-depth discussions with customers, both sides explored opportunities for collaborative innovation across the upstream and downstream of the biopharmaceutical industry chain, focusing on the integration of technological breakthroughs and industrial applications, jointly injecting new momentum into the high-quality development of the industry.
